Economics Analysis of Dapagliflozin Compare to Sulfonylurea in the Treatment of Type 2 Diabetes Mellitus in Spain- Cost of Achieving Composite Endpoints

Nov 1, 2015, 00:00
10.1016/j.jval.2015.09.2110
https://www.valueinhealthjournal.com/article/S1098-3015(15)04186-8/fulltext
Title : Economics Analysis of Dapagliflozin Compare to Sulfonylurea in the Treatment of Type 2 Diabetes Mellitus in Spain- Cost of Achieving Composite Endpoints
Citation : https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(15)04186-8&doi=10.1016/j.jval.2015.09.2110
First page : A609
Section Title : Research Podium Presentations - Session 1 and Session 2
Open access? : No
Section Order : 1525
Categories :
Tags :
Regions :
ViH Article Tags :